Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Ab&B Bio-Tech CO., LTD. JS Class H ( (HK:2627) ) is now available.
Ab&B Bio-Tech CO., LTD. JS announced that non-executive director and Audit Committee member Cheng Qianwen has tendered his resignation to focus on personal pursuits, but will remain in his roles until shareholders elect a new non-executive director so that the Audit Committee continues to comply with regulatory requirements on its minimum membership. The company also reported the resignation of board secretary and joint company secretary Zhang Yangyang, effective 12 January 2026, noting she leaves without disagreement, while the remaining joint company secretary, Lin Sio Ngo, will continue as company secretary, helping ensure continuity in corporate governance and compliance functions despite the leadership changes.
The most recent analyst rating on (HK:2627) stock is a Hold with a HK$39.00 price target. To see the full list of analyst forecasts on Ab&B Bio-Tech CO., LTD. JS Class H stock, see the HK:2627 Stock Forecast page.
More about Ab&B Bio-Tech CO., LTD. JS Class H
Ab&B Bio-Tech CO., LTD. JS is a joint stock company incorporated in the People’s Republic of China and listed in Hong Kong (stock code: 2627). The company operates in the biotechnology sector, though the announcement focuses primarily on its corporate governance and board composition rather than detailing its specific products, services or market segments.
Average Trading Volume: 176,703
Technical Sentiment Signal: Strong Sell
See more insights into 2627 stock on TipRanks’ Stock Analysis page.